en · de · es · fr · pt
sr9009-notes.peptides6088.com › Blog › Background And Receptor Mechanism — Complete Guide

Background And Receptor Mechanism — Complete Guide

By Editorial Desk · published 2025-08-16 · last reviewed 2025-09-07 · Blog

A practical reference on storage stability: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

This page was last updated on 2025-09-07 and is reviewed periodically as new material appears.

Background and Receptor Mechanism

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ, also called NR1D1 and NR1D2. These receptors help regulate circadian rhythms and metabolic gene programs. The compound was developed for laboratory research, not as an approved therapeutic. Its identity is distinct from steroid hormones and selective androgen receptor modulators. Scientific interest centers on how REV-ERB activation changes gene expression in cells and animal models.

At the molecular level, SR9009 binds the ligand-binding domain of REV-ERB and strengthens recruitment of corepressor proteins such as NCoR and HDAC3. This increases repression of target genes, including Bmal1 and other clock-controlled and metabolic genes. In rodent studies, such changes have been linked to altered lipid handling, glucose metabolism, and energy expenditure. The precise chain of events between receptor binding and whole-body effects remains an active area of research. Findings in animals do not automatically translate to humans.

Identity, Handling, and Regulation

In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.

Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.

Sr9009 at a glance

PropertyValueNotes
Chemical classSynthetic small moleculeStudied as a REV-ERB agonist
Molecular formulaC20H24ClN3O4SReported for the neutral compound
AppearanceOff-white to pale yellow solidTypical research-grade material
SolubilitySparingly soluble in waterSoluble in solvents such as DMSO
Common synonymsSR9009; StenabolicStenabolic is an informal alias

SR9009 Handling and Quality Control

Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.

SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.

Related pages on this site

Background and Mechanism

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.

At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.

Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.

Reference notes

=== Market withdrawal === Conjugated estrogens oral (Cenestin; synthetic conjugated estrogens) – estrogen (estrogen receptor agonist) – atrophic vaginitis [153] Testosterone transdermal (Intrinsa; Intrinsa CHF; Livensa; Testosterone transdermal TheraDerm MTX; WC3048; WC3049) – androgen (androgen receptor agonist) – female sexual dysfunction [154]

Thus, the two substrates of this enzyme are isopregnanolone and oxidised nicotinamide adenine dinucleotide phosphate (NADP+). Its products are 5α-dihydroprogesterone, reduced NADPH, and a proton. This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-OH group of donor with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is 3β-hydroxy-5α-steroid:NADP+ 3-oxidoreductase.

After the tumult died down to some extent, live TV service resumed as Ceaușescu announced that a decision had been taken that morning to raise several allowances, including the minimum wage, from 2,000 to 2,200 lei per month (an increase of 13 U.S. dollars at the time), and the old age pension from 800 to 900 lei per month. Ceaușescu continued his speech, addressing the events of Timișoara and blaming them on imperialist circles and intelligence services that wished to destroy the integrity and sovereignty of Romania and halt the construction of socialism. He continued in this nationalist and Marxist–Leninist vein, referencing his speech of 21 August 1968, where he had asserted Romania's independence within the Warsaw Pact at the time of the invasion of Czechoslovakia, and promising to continue to defend socialist Romania as before. In all, following the interruption, the speech and the associated exhortations continued for over 13 minutes, and ended with Ceaușescu waving to the crowd.

Sources: en.wikipedia.org

Reference notes

=== Response from political organizations === Health Care Without Harm opposes the use of recombinant bovine growth hormone due to its adverse impacts on animals and potential harm to humans. Oregon Physicians for Social Responsibility recommends buying products from cows not injected with recombinant bovine growth hormone (rBGH or rBST).

Alkaloids containing a pyridine unit (pyridine alkaloids) occur frequently in insects, amphibians, and marine animals, as well as widely in plants. Many representatives occur in Virginian tobacco (Nicotiana tabacum). These include the principal alkaloid nicotine, as well as nornicotine, anabasine, and anatabine. Other compounds of this group are found in cordworms. Anabaseine occurs in the genus Paranemertes. In Amphiporus angulatus, 2,3'-bipyridine is found, as well as the main component nemertelline, which consists of four pyridine units. Pyridine alkaloids also occur in the genus fire ants (Solenopsis), including the red fire ant (Solenopsis invicta). These include, for example, 2-methyl-6-undecylpyridine and 2-methyl-6-tridecylpyridine, as well as related compounds with unsaturated side chains. The venom in the skin of the three-striped treehopper (Epipedobates tricolor) contains the pyridine alkaloid epibatidine.

=== Crystal Anderson-Conner === Crystal Anderson-Conner is played by Natalie West. Crystal is a close friend of Roseanne, having gone to high school with her and Jackie and later working together with them at Wellman Plastics. A mild-mannered, good-hearted woman, Crystal's kindness is often taken advantage of, even by Roseanne at times. Though Crystal is not oblivious to others using her, she seldom asserts herself, fearing she might lose others' favor or be perceived as unladylike. Crystal's most poignant hallmark is her dating troubles. At the beginning of the series, she has been married three times. Both her marriages to Rusty and Travis, were fairly short and ended in divorce. (However, in season 1, episode 5, it is mentioned that she was widowed at 18.) Her third husband Sonny, the father of her son Lonnie, was killed in a bridge construction accident. After, Crystal endures years of bad relationships before gradually kindling a romance with Dan's father Ed, much to Roseanne's surprise and Dan's consternation. When Crystal and Ed become engaged in Season 3, she reveals she is pregnant. Dan is initially unhappy with either development, further straining his already-difficult relationship with his father. Crystal gives birth to Ed Junior, better known as Little Ed; the following year, she gives birth to her daughter, Angela. Crystal made a few appearances in several revival-era episodes in 2018 and 2019. It is unmentioned if she is still married to Ed Conner. However, in The Conners, when Ed, Sr. dies, he was living alone in rather shabby circumstances.

== Career == After postdoctoral research at AMOLF (FOM Institute for Atomic and Molecular Physics, Amsterdam) and University of Minnesota, Hamley was appointed as lecturer in Physics at the University of Durham in 1993 where he worked until 1995. He moved to the Department of Chemistry at the University of Leeds in 1995 and was promoted to become Professor of Polymer Materials and Director of the Centre for Self-Organising Molecular Systems in 2004. He moved to the University of Reading as Diamond Professor of Physical Chemistry in 2005. This was a five-year, joint appointment with Diamond Light Source. His past research concerned the self-assembly of block copolymers. Most recently he has developed interests in peptide and peptide conjugate self-assembly, including molecules with bioactivity such as amyloid peptides peptide hormones, antimicrobial peptides, peptides in cosmetic applications and peptides with anti-cancer activity. Several of these show promise as therapeutics.

Sources: en.wikipedia.org

Notes from published material

October 27, 1946: The Preamble to the Constitution of October 27, 1946, establishes the Fourth Republic in France; it includes in paragraph 3 the statement: "The law guarantees women equal rights with men in all areas."

=== 4. Periodontal ligament === The periodontal ligament is the principal connective tissue structure anchoring the tooth to the surrounding alveolar bone. During clinical attachment loss, the collagen fiber bundles are progressively destroyed. The most apical extent of the remaining periodontal ligament shifts downward along the root surface, corresponding directly to the measured level of clinical attachment loss.

== Diagnosis == There are various tools that can be used to help diagnose myositis. The most common methods are physical examination, electromyography (EMG), magnetic resonance imaging (MRI), muscle biopsy, and blood tests. The first course of action a doctor will likely take is perform a physical exam. The doctor assesses for muscle weakness or rashes. Another possible test is electromyography. This test involves the insertion of small needles into the patient's muscles. This allows a physician to look at the muscles' responses to various electrical nerve stimuli and evaluate which muscles potentially have myositis. Magnetic resonance imaging can be useful in diagnosis, allowing painless, non-invasive visualisation of any muscle wastage. Muscle biopsies, however, are the most reliable tests for diagnosing myositis. There are also a variety of blood tests available that help in the diagnosis of myositis. The doctor may look for an elevation of creatine kinase in the blood, which is indicative of muscle inflammation. Certain autoantibodies (antibodies that target muscle cells) can also be found in the blood, which can indicate that myositis is caused by an autoimmune disease. Some specific examples of autoantibodies are Anti-Jo-1, Anti-HMGCR, Anti-TIF1, etc.

Sources: en.wikipedia.org

Frequently asked questions

What is SR9009?

SR9009 is a synthetic research compound that activates the REV-ERBα and REV-ERBβ nuclear receptors. It is not an approved drug and has no established human therapeutic use. Most published biological data come from cell and rodent studies.

Is SR9009 a SARM?

No. SR9009 is frequently mislabeled as a SARM in online discussions, but it does not target androgen receptors. Its known mechanism involves REV-ERB nuclear receptors and circadian-metabolic gene regulation.

What human data exist for SR9009?

Human clinical data are very limited. There is no approved human use, and safety and efficacy in people are not established. Most evidence comes from preclinical models, so effects observed in animals may not apply to humans.

How is SR9009 usually analyzed?

Liquid chromatography–mass spectrometry is common for identity and purity checks. High-performance liquid chromatography with ultraviolet detection can also be used. Both methods require a suitable reference standard.

Network